✦ LIBER ✦

Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia

✍ Scribed by Giovanni Mantovani; Antonio Macciò; Clelia Madeddu; Roberto Serpe; Giorgia Antoni; Elena Massa; Mariele Dessì; Filomena Panzone

Publisher: Springer
Year: 2009
Tongue: English
Weight: 179 KB
Volume: 88
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s00109-009-0547-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a pilot study of the effects

Results of a pilot study of the effects of celecoxib on cancer cachexia in patients with cancer of the head, neck, and gastrointestinal tract

✍ Victor Lai; Jonathan George; Luther Richey; Hong J. Kim; Trinitia Cannon; Carol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 2 views

## Abstract ## Background. Animal models suggest that cyclooxygenase‐2 (COX‐2) inhibitors may be beneficial in suppressing cancer cachexia. We investigated the effect of short‐course celecoxib on body composition, inflammation, and quality of life (QOL) in patients with cancer cachexia in a phase

The effect of COX-2 inhibitor on capecit

The effect of COX-2 inhibitor on capecitabine-induced hand–foot syndrome in patients with stage II/III colorectal cancer: a phase II randomized prospective study

✍ Rong-Xin Zhang; Xiao-Jun Wu; Shi-Xun Lu; Zhi-Zhong Pan; De-Sen Wan; Gong Chen 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 154 KB

A phase II study of the safety and effic

A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer

✍ Leena Gandhi; Matthew W. Harding; Marcus Neubauer; Corey J. Langer; Melvin Moore 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Phase II study evaluating the efficacy a

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

✍ Phuong K. Morrow; Stephen Divers; Louise Provencher; Shiuh-Wen Luoh; Teresa M. P 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 226 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Comparing safety and efficacy of first-l

Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer : Findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study

✍ Nadine A. Jackson; José Barrueco; Raoudha Soufi-Mahjoubi; John Marshall; Edith M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views